Such investigations will be crucial to determine whether PPG neurons and their GLP-1 release will become a valuable tool in clinical practice for obesity treatment or is linked to too many adverse effects such as stress or anxiety. The gene discussed is GCG; the disease is obesity due to melanocortin 4 receptor deficiency.